HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Identification of a competing endogenous RNA axis related to gastric cancer.

Abstract
Competing endogenous RNA (ceRNA) pathways play pivotal roles in the formation and progression of gastric cancer (GC). Employing multi-omics analysis, we sought to identify a ceRNA network associated with GC progression. We analyzed3Gene Expression Omnibus datasets as well as data from The Cancer Genome Atlas to identify genes that were differentially expressed in GC tissues. A total of 84 upregulated genes and 106 downregulated genes were found. Enrichment analysis indicated that some pathways were strongly linked with tumor formation and progression. We also screened hub genes to establish a lncRNA-miRNA-mRNA network. We ultimately identified 8 hub genes, 6 key miRNAs and 4 key lncRNAs that interact within a common ceRNA network. Correlation analysis and in vitro experiments were conducted to verify the regulatory effect of the ceRNA network in GC. A knockdown assay confirmed that the DLGAP1-AS1/miR-203a-3p/THBS2 axis is a ceRNA network involved in GC progression. In this study, we elucidated the role of the DLGAP1-AS1/miR-203a-3p/THBS2 ceRNA network in the progression of GC. These molecules maybe evaluated as therapeutic targets and prognostic biomarkers for GC.
AuthorsFuqiang Zu, Hezhou Han, Weiwei Sheng, Jian Sun, Hui Zang, Yu Liang, Qingfeng Liu
JournalAging (Aging (Albany NY)) Vol. 12 Issue 20 Pg. 20540-20560 (10 20 2020) ISSN: 1945-4589 [Electronic] United States
PMID33080572 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • MicroRNAs
  • RNA, Long Noncoding
  • RNA, Messenger
Topics
  • Disease Progression
  • Humans
  • MicroRNAs (physiology)
  • RNA, Long Noncoding (physiology)
  • RNA, Messenger (physiology)
  • Stomach Neoplasms (genetics, pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: